SLNO:NASDAQSoleno Therapeutics, Inc. Analysis
Data as of 2026-08-31 - not real-time
€0.14
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At €0.1365, SLNOV5.MI shows no decisive moving-average alignment, leaving the trend neutral.
Risk comes out at 7 of a possible 10, a elevated reading. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Risk comes out at 7 of a possible 10, a elevated reading. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Thin trading liquidity raises execution risk
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Thin trading liquidity raises execution risk
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Thin trading liquidity raises execution risk
Key Metrics & Analysis
Technical Analysis
TrendNeutral
MACDNeutral
VolumeStable
Fear & Greed Index94
Valuation
GradeFair
TypeBlend
Risk Assessment
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.